The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy

J Acquir Immune Defic Syndr. 2004 May 1;36(1):641-2. doi: 10.1097/00126334-200405010-00015.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Cohort Studies
  • Female
  • HIV Infections / blood*
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepatitis C / blood*
  • Hepatitis C / complications
  • Humans
  • Hyperlipidemias / chemically induced*
  • Male
  • Risk Factors